Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 33342-106

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 33342-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30s (30s Container)

This is a medication containing a combination of Emtricitabine and Tenofovir Disoproxil Fumarate in the form of tablets, with each tablet containing 200 mg of emtricitabine and 300 mg of tenofovir disoproxil. The usual dosage instructions are not provided, and the package should be stored below 30°C. The medication should be provided to patients with an enclosed medication guide. The manufacturer is Macieods Pharma USA, Inc, based in Princeton, NJ, and the medication is distributed in containers tightly closed, keeping in the original container.*

FDA Label Image

Emtri (Structure Emtricitabine)

FDA Label Image

Structure-tenofovir (Structure Tenofovir)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.